Saturday, October 18, 2014

Top High Dividend Stocks To Buy For 2014

Popular Posts: 5 Cheap Dividend Stocks to Buy5 Stocks to Buy in April4 Medical Marijuana Stocks to Dump Now Recent Posts: 5 High-Yield, Large-Cap Dividend Stocks to Buy PHOT Suspended by SEC – Sell Your Marijuana Stocks (While You Still Can) Yes, You SHOULD Kill BlackBerry Phones to Save BBRY View All Posts

It’s hard to beat dividend stocks like real estate investments trusts (REITs) and master limited partnerships (MLPs) for high dividend yields, but since those payouts flow directly from earnings, their income streams can be volatile. (Hey, as with everything else in investing and life, there’s no such thing as a free lunch.)

Hot Internet Stocks To Invest In 2015: John Wiley & Sons Inc (JWA)

John Wiley & Sons, Inc., incorporated on January 15, 1904, is a global provider of knowledge and knowledge-based services in areas of research, professional development and education. Core businesses produce scientific, technical, medical and scholarly research journals, reference works, books, database services, and advertising; professional books and certification, assessment and training services, and education content and services, including online program management for colleges and universities and integrated online teaching and learning resources for instructors and students. The Company sells its products to customers in the Middle East (including Iran and Syria), Africa (including Sudan), Cuba, and other developing markets where it does not have operating subsidiaries. In April 2014, the Company acquired Profiles International, a provider of employment assessment and talent management solutions.

Research

The Company�� Research business serves the world�� research and scholarly communities and is a publisher for professional and scholarly societies. Research�� mission is to support researchers, professionals and learners in the discovery and use of research knowledge to achieve results that help shape the future. Research products include scientific, technical, medical and scholarly research journals, books, major reference works, databases, clinical decision support tools and laboratory manuals and workflow tools, in the publishing areas of the physical sciences and engineering, health sciences, social science and humanities and life sciences. Research customers include academic, corporate, government, and public libraries; researchers; scientists; clinicians; engineers and technologists; scholarly and professional societies, and students and professors. The Company�� Research products are sold and distributed globally, online and in print through multiple channels, including research libraries and library consortia, independent subscription agents, direct sa! les to professional society members, bookstores, online booksellers and other customers. Publishing centers include Australia, Germany, India, Singapore, the United Kingdom and the United States. Research accounted for approximately 57% of total Company revenue (fiscal 2013). The Company�� Research business is a provider of content and services in evidence-based medicine (EBM). Through the Company�� alliance with The Cochrane Collaboration, the Company publishes The Cochrane Library.

Wiley Online Library, the online publishing platform for the Company�� Research business, is a multidisciplinary collections of online resources covering life, health and physical sciences, social science and the humanities. Wiley Online Library delivers seamless integrated access to over four million articles from 1,500 journals, 13,000 online books, and hundreds of reference works, laboratory protocols and databases. Wiley Online Library provides the user with intuitive navigation, enhanced discoverability, expanded functionality and a range of personalization options. Wiley Open Access is the Company�� publishing program for open-access research articles. Under the Wiley Open Access business model, research articles submitted by authors are published and compiled by subject area into open-access journals. In addition to Wiley Open Access, the Company provides authors with the opportunity to make their individual research articles that were published within the Company�� paid subscription journals freely available to the general public through OnlineOpen.

Professional Development (PD)

The Company�� Professional Development business acquires, develops and publishes professional books, subscription products, certification and training services and online applications in the areas of business, finance, accounting, workplace learning, management, leadership, technology, behavioral health, engineering/ architecture and education. Products are developed in print and digitally ! for world! wide distribution through multiple channels, including major chains and online booksellers, independent bookstores, libraries, colleges and universities, warehouse clubs, corporations, direct to consumer, websites and other online applications. Publishing centers include Australia, Canada, Germany, India, Singapore, the United Kingdom and the United States. Professional Development accounted for approximately 24% of total Company revenue in fiscal year 2013. Professional Development revenue by product type includes eBooks and Print Books; Online Training and Assessment which is revenue from the sale of products and services focusing on workplace effectiveness and career success; Publishing Rights which is revenue from the licensing of the right to republish Wiley content either online or in print; Journal Subscriptions online and in print to professionals, and Other.

Education

The Company�� Education business produces educational content and services, including online program management for colleges and universities and integrated online teaching and learning resources for instructors and students. Education�� mission is to help teachers teach and students learn by delivering to students, faculty and institutions throughout the world personalized content, tools and services that demonstrate results. Education offers products and services principally delivered through college bookstores and online distributors, with customers having access to content in multi-media formats, as well as the traditional textbook. Education�� solutions are available in each of its publishing disciplines, including the sciences, engineering, computer science, mathematics, business and accounting, statistics, geography, hospitality and the culinary arts, education, psychology and modern languages. Education accounted for approximately 19% of total Company revenue in fiscal year 2013. Education revenue by product type includes eBooks and Print Textbooks; Online Program Management; WileyPLUS, the ! Company�! � online learning solution; revenue from the licensing of publishing content rights and Other Nontraditional and Digital Products, such as custom publishing and other content adaption��.

Education offers online learning solutions including WileyPLUS, it�� research-based, online environment for effective course teaching and learning that is integrated with a complete digital textbook. WileyPLUS improves student learning through instant feedback, personalized learning plans, and self- evaluation tools and a range of course-oriented activities, including online planning, presentations, study, homework and testing. The Company also provides the services of the Wiley Faculty Network, a global community of faculty that offers guidance, training, and resources. Through the Wiley Faculty Network, instructors and administrators can collaborate with each other, attend virtual and live events, and utilize a wealth of resources all designed to help them grow as educators.

Journal Products

The Company publishes approximately 1,600 Research and Professional Development journals. Journal subscription revenue and other related publishing income, such as advertising, backfile sales, the licensing of publishing rights, journal reprints and individual article sales accounted for approximately 48% of the Company�� consolidated fiscal year 2013 revenue. The journal portfolio includes titles owned by the Company, in which case they may or may not be sponsored by a professional society; titles owned jointly with a professional society; and titles owned by professional societies and published by the Company pursuant to long-term contracts. The Company also enters into agreements with outside independent editors of journals that state the duties of the editors, and the fees and expenses for their services. The Company sells journal subscriptions directly through Company sales representatives; indirectly through independent subscription agents; through promotional campaigns, and thro! ugh membe! rships in professional societies for those journals that are sponsored by societies. Journal subscriptions are primarily licensed through contracts for online content delivered through the Company�� online platform, Wiley Online Library.

Book Products

The Company�� Book products and book related publishing revenue, such as advertising and the sale of publishing rights, accounted for approximately 48% of the Company�� fiscal year 2013 revenue. The Company enters into agreements with authors that state the terms and conditions under which the materials will be published, the name in which the copyright will be registered, the basis for any royalties, and other matters. The Company develops content in a digital format that can be used for online and print products, resulting in productivity and efficiency savings, and enabling print-on-demand delivery. Book content is available online through Wiley Online Library, WileyPLUS, Custom Select and other platforms. Ebooks are delivered to intermediaries, including Amazon, Apple and Google for re-sale to individuals in various industry-standard formats, which are now also the preferred deliverable for licensees of all types, including foreign language publishers.

Other Digital Products and Services

The Company is focused on delivering content-enabled services which improve learning, career management and effectiveness for its target communities. The Inscape and ELS businesses, along with the Company�� Pfeiffer brand, represent the Company�� professional training and assessment services. These businesses offer a variety of classroom learning solutions and e-learning activities that are delivered to customers directly through online digital delivery platforms and also through an authorized distributor network of independent consultants, trainers and coaches. The Company�� professional training and assessment services offer highly flexible packages and modules for its customers that include online pre-w! ork and p! rofile assessments, self-study materials, online videos, mobile apps and other sophisticated planning tools.

The Company generates advertising revenue from print and online journal subscription products; its online publishing platform, Wiley Online Library; the Wiley Job Network, a full service online job board; online events such as webinars and virtual conferences; community interest websites such as spectroscopyNOW.com and websites for the Company�� brands like Dummies.com. The Company�� publications and services are sold throughout most of the world through operations located in Europe, Canada, Australia, Asia, and the United States.

Advisors' Opinion:
  • [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

    John Wiley & Sons Inc.(JWA) on Tuesday said it agreed to buy privately held French management solutions company CrossKnowledge for $175 million in cash. CrossKnowledge’s customizable offerings–including skills assessment, training and certifications–are delivered through a cloud-based platform.

Top High Dividend Stocks To Buy For 2014: Analytica Bio - Energy Corp (ABEC)

Analytica Bio-Energy Corp., formerly Uniwell Electronic Corporation, incorporated on January 12, 2004, is a company with water purification system. The Company was a shell company.

The Company focused on acquiring an active business. In September 2013, the Company changed its name to Analytica Bioenergy, Inc.

Advisors' Opinion:
  • [By Dan Burrows]

    Most importantly, on days when this penny stock did see heavy volume, it tumbled — a classic red flag for the “dump” part of pump-and-dump schemes, which penny stocks are ripe for.

    Top Penny Stocks: Analytica Bio-Energy Corp. (ABEC)

    YTD Performance: 29,300%
    52-Week Range: $0.0017 – $0.50
    Average Volume (3 months): 9,574
    Market Cap: $10.6 million

Top High Dividend Stocks To Buy For 2014: New Residential Investment Corp (NRZ)

New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate. On May 15, 2013, Newcastle Investment Corp. announced that the spin-off of New Residential Investment Corp.

The Company is managed by an affiliate of Fortress Investment Group LLC, a global investment management. The Company primarily target investments in excess mortgage servicing rights, residential mortgage backed securities, residential mortgage loans and other related investments.

Advisors' Opinion:
  • [By Lauren Pollock]

    New Residential Investment Corp.(NRZ) and other investors agreed to buy about $3.2 billion of servicing advances from Nationstar Mortgage Holdings Inc.(NSM), part of Nationstar’s plan to reconfigure its acquisition structure. The advances relate to nonagency residential mortgage loans with an unpaid principal balance of about $58 billion. Nationstar shares rose 4.1% to $42.50 in light premarket trading.

Top High Dividend Stocks To Buy For 2014: Ambit Biosciences Corp (AMBI)

Ambit Biosciences Corporation, incorporated on May 17, 2000, is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company�� lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company�� second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company�� third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.

Quizartinib

The Company�� lead drug candidate, quizartinib, is a once-daily, orally-administered, potent and selective inhibitor of FLT3, a validated target in the treatment of AML, and is in Phase IIb clinical development. The FLT3-ITD mutation acts like a power switch that causes leukemic cells, or blasts, to spread more aggressively and grow back more rapidly following chemotherapy, conferring an especially poor survival outcome. Quizartinib is designed to turn off this switch. The Company is developing a companion diagnostic test with Genoptix Medical Laboratory, a Novartis company, to identify FLT3-ITD positive patients.

AC410

The Company�� advanced drug candidate, AC410, is a potent, selective, orally-administered, small molecule inhibitor of JAK2, which has potential utility for the treatment of autoimmune and inflammatory diseases. Signaling through JAK controls the activation, proliferation and survival of various types of immune cells, and overactivation of such cells can exacerbate a range of normal inflammatory processes, resulting i! n inflammation. The Company�� initial JAK2 drug candidate, AC430, is a racemic mixture (50/50) of two enantiomers (mirror images), AC410 and AC409, and was studied in a Phase I clinical trial.

CSF1R Program

The Company is developing two potent and exquisitely selective small molecule compounds, AC708 and AC855 that both inhibit CSF1R and have potential utility in oncology, autoimmune and inflammatory diseases. Signaling through CSF1R controls the activation, proliferation and survival of macrophages, which are key mediators of immune system function and over-activation of macrophages, may result in exacerbation of certain diseases.

The Company competes with Abbvie Inc., Akinion Pharmaceuticals AB, Amgen Inc., ARIAD Pharmaceuticals, Inc., AROG Pharmaceuticals, LLC, ArQule, Inc., Astellas, AstraZeneca plc, Bayer AG, Celgene Corporation, Daiichi-Sankyo Company Limited, Galapagos NV, GlaxoSmithKline plc, Incyte Corporation, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Novartis, Onyx Pharmaceuticals, Inc., Pfizer, Rigel Pharmaceuticals, Inc., F. Hoffman-LaRoche Ltd, and Vertex Pharmaceuticals Incorporated.

Advisors' Opinion:
  • [By Wallace Witkowski]

    Ambit Biosciences Corp. (AMBI) �shares fell more than 37% to $8 in moderate volume. The small-cap biotech said it will not file an accelerated approval application with the Food and Drug Administration for its leukemia drug quizartinib after the agency disagreed with the company about the use of certain study data to support the drug�� efficacy.

Top High Dividend Stocks To Buy For 2014: BCE Inc. (BCE)

BCE Inc. provides communications solutions to residential, business, and wholesale customers primarily in Canada. The company offers local and long distance telephone services under the Bell Home Phone brand; direct-to-home satellite television (TV) services under the Bell TV name; Internet protocol TV services under the Bell Fibe TV brand; and personal video recorders and online access services. It also provides data services, including Internet access services under the Bell Internet name; Internet protocol based services; and information and communications technology solutions. In addition, the company engages in the rental, sale, and maintenance of business terminal equipment; sale of TV set-top boxes; and provision of network installation and maintenance services for third parties. Further, it offers wireless voice and data communications products and services, such as call display and voicemail, e-mail, Web browsing, social networking, text, picture and video messagi ng, music downloads, ring tunes, ringtones, games and applications, video streaming, live TV, mobile Internet, roaming, and global positioning system navigation services under the Bell and Virgin Mobile brands. Additionally, the company provides media services comprising TV programming services to broadcast distributors. It operates approximately 28 conventional over-the-air stations and 30 English and French-language specialty TV channels; 33 FM and AM radio stations and their related Websites; and Theloop.ca Website. As of December 31, 2012, the company served approximately 2.1 million high-speed Internet access customers through fiber-optic, digital subscriber line, or wireless broadband technology; and 7.7 million wireless customers. BCE Inc. offers its services through call centre representatives, independent dealer stores, and value-added resellers, as well as through its Websites. The company was founded in 1880 and is headquartered in Verdun, Canada.

Advisors' Opinion:
  • [By Gerrit De Vynck]

    Nadir Mohamed has been overshadowed for much of his tenure as head of Rogers Communications Inc. (RCI/B) by the dealmaking of his main rival, George Cope at BCE Inc. (BCE)

  • [By Holly LaFon]

    Dalio�� next largest purchase was Berkshire Hathaway Inc. (BRK.B), and three new buys: BCE Inc. (BCE), The Goldman Sachs Group Inc. (GS), and Peabody Energy Corp. (BTU).

  • [By Dan Caplinger]

    The big news for Madison Square Garden has been the success of its key sports franchises. The New York Knicks basketball team made the playoffs and earned the No. 2 seed in the Eastern Conference. Even more importantly, the long-delayed National Hockey League season finally got going in January, helping resurrect what many had feared would be a lost season, sending shares of MSG, as well as Canadian venue/team-owners Rogers Communications (NYSE: RCI  ) and BCE (NYSE: BCE  ) , higher. As it turned out, MSG's New York Rangers made the playoffs and will go up against the Washington Capitals in the first round. Playoffs are an especially lucrative time for sports viewership, and usually translate into extra profits for the company's broadcast businesses.

  • [By Alex Planes]

    Excel became the youngest company to earn a billion dollars annual revenue that year, and was also considered the fourth-largest long-distance carrier by the end of 1996. But the flaws in its business model became too great to ignore as more Americans shifted their calling preferences to mobile phones. Profits plummeted, and after the turn of the century Bell Canada (NYSE: BCE  ) , a major shareholder, acquired full control. Excel became a Bell Canada subsidiary, but was quickly spun off as a new privately held company, only to have this new corporate parent file for bankruptcy in 2004. After emerging from bankruptcy, the former Excel was eventually acquired by another privately held telecom provider. It wasn't the first or the fastest to go big and then go bust, but Excel's story highlights the risks any investor takes in buying up shares based on a very brief history of meteoric growth.

Top High Dividend Stocks To Buy For 2014: Guggenheim CurrencyShares Japanese Yen Trust (FXY)

Guggenheim CurrencyShares Japanese Yen Trust, formerly CurrencyShares Japanese Yen Trust, is a grantor trust. The Trust issues shares (the Shares) in blocks of 50,000 (a Basket) in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with the redemption of Baskets. The investment objective of the Trust is for the Shares to reflect the price of Japanese Yen plus accrued interest, if any, less the expenses of the Trust�� operations. The Trust holds Japanese Yen and, from time to time, issues Baskets in exchange for deposits of Japanese Yen and distributes Japanese Yen in connection with redemptions of Baskets. The Sponsor of the Trust is Guggenheim Specialized Products, LLC, a Delaware limited liability company.

The Bank of New York Mellon, a banking corporation with trust powers organized under the laws of the State of New York, serves as the Trustee. The Shares are backed by the assets of the Trust, which does not hold or use derivative products.

Advisors' Opinion:
  • [By MONEYMORNING]

    More sophisticated traders may choose to buy put options on CurrencyShares Japanese Yen Trust (NYSE Arca: FXY), or call options on YCS to pair with shares of AMLP, but that's just a matter of preference.

No comments:

Post a Comment